Feng Li

8PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2024
CAR T Cells Engineered to Secrete IFNκ Induce Tumor Ferroptosis via an IFNAR/STAT1/ACSL4 Axis.

Yaoxin Gao, Shasha Liu, Yifan Huang

|Jan 31, 2024
Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'.

Jinyan Liu, Huanan Chen, Caijuan Guo

|Nov 28, 2023
MDSCs-derived GPR84 induces CD8+ T-cell senescence via p53 activation to suppress the antitumor response.

Jinyan Liu, Jiayin Liu, Guohui Qin

|May 17, 2022
High Mobility Group Protein B1 Decreases Surface Localization of PD-1 to Augment T-cell Activation.

Qun Gao, Shumin Wang, Feng Li

|Oct 07, 2020
Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy.

Zhen Zhang, Xinfeng Chen, Yonggui Tian

|May 29, 2014
Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer.

Jie-Yao Li, Xiu-Fang Duan, Li-Ping Wang

Pageof 2